1. Bemiller J.N.: Trends in industrial polysaccharide research, pp. 517–535 inBiomedical and Biotechnological Advances in Industrial Polysaccharides (V. Crescenzi, Ed.) Gordon and Breach Science Publishers, New York 1989.
2. Cawley S., Ormrod D.J., Miller T.E.: Immunopotentiation in infections disease: Effect of glucan and lentinan on host defences and experimental infections.Int. J. Immunother. 3, 159–170 (1987).
3. Czop J.K., Austen K.F.: Properties of glucans that active the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.J. Immunol. 135, 3388–3393 (1985).
4. Demleitner S., Kraus J., Franz G.: Synthesis and antitumour activity of sulfoalkyl derivatives of curdlan and lichenan.Carbohydr. Res. 226, 247–252 (1992).
5. Koníček J., Lasík J., Wurst M.: Production and characteristics of the exocellular polysaccharide in mutant strains ofXanthomonas fuscans.Folia Microbiol. 22, 12–18 (1977).